A
Altos Labs
Biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming
At a glance
- Founded
- 2021
- Headquarters
- Los Altos, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tier
Knowledge graph
News
Luma Group closes debut life sciences fund at $410M
Sep 9, 2026
Market map
billionaire funded longevity startups
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- YMYuri Milner
ARCH Venture Partners- JBJeff Bezos
Bezos Expeditions
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
13 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Altos Labs was the backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
1 deals across Altos Labs's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Altos Labs's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Altos Labs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Altos Labs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.